|Day Low/High||4.20 / 5.91|
|52 Wk Low/High||1.63 / 15.96|
BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.
Shares of BioCryst (BCRX) fell double digits despite topping analysts' 4Q expectations.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioCryst Pharmaceuticals, Inc. , where a total of 16,282 contracts have traded so far, representing approximately 1.6 million underlying shares.
Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.
Synergy Pharmaceuticals, Arrowhead Pharmaceuticals and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Wednesday.
Investors considering a purchase of BioCryst Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $5.90/share, might benefit from considering selling puts among the alternative strategies at their disposal.
The number of new 12-month highs has climbed to 240.
The euphoria has calmed down, and if stocks can consolidate, we will have some better entry points.
Investors eyeing a purchase of BioCryst Pharmaceuticals, Inc. shares, but cautious about paying the going market price of $4.61/share, might benefit from considering selling puts among the alternative strategies at their disposal.
These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits